New developments for optimal management of head and neck cancer

Onkologie

Volumn 27, Issue 4, 2004, Pages 339-342

  Ren Leemans, C ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; RECOMBINANT DNA; RETINOID DERIVATIVE;

CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOGENESIS; DRUG MECHANISM; EDITORIAL; GENE THERAPY; HEAD AND NECK CARCINOMA; HUMAN; LYMPH NODE METASTASIS; QUALITY OF LIFE; TOXICITY; TREATMENT OUTCOME;

CARCINOMA, SQUAMOUS CELL; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; OTORHINOLARYNGOLOGIC NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RISK FACTORS;

EID: 4644324513     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079085     Document Type: Editorial

References (23)

1. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK: Head and neck cancer. N Engl J Med 1993; 328:184-194.
2. Dietz A, Logothetis CA, Helbig M, Fletchenmacher C, Rudat V, Dollner R, Wallner F, Bosch FX: Prognostic impact of EBV-related LMP-1, histologic type, and environmental factors in nasopharyngeal carcinoma in a German population. Onkologie 2004;27:345-350.
3. Glover KY, Papadimitrakopoulou VA: Chemoprevention of head and neck cancer. Curr Oncol Rep 2003;5:152-157.
4. Braakhuis BJ, Tabor MP, Leemans CR, van der Waal I, Snow GB, Brakenhoff RH: Second primary tumors and field cancerization in oral and oropharyngeal cancer: Molecular techniques provide new insights and definitions. Head Neck 2002;24:198- 206.
5. Görögh T, Berwig J, Sola N, Lippert BM: Differential regulation of MAPK (JNK 3) gene expression in human head and neck squamous cell carcinoma. Onkologie 2004;27:353-357.
6. Regelink G, Brouwer J, Bree R de, Pruim J, Laan BFAM van der, Vaalburg W, Hoekstra OS, Comans EFI, Vissink A, Leemans CR, Roodenburg JLN: Detection of unknown primary tumours and distant metastases in patients with cervical metastases: Value of FDG-PET versus conventional modalities. Eur J Nucl Med 2002;29:1024-1030.
7. Rudat V, Pfreunder L, Hoppe F, Dietz: Approaches to preserve the larynx function in locally advanced laryngeal and hypopharyngeal cancer. Onkologie 2004;27:368-375.
8. Bradford CR, Zhu S, Wolf GT, Poore J, Fisher SG, Beals T, McClatchey KD, Carey TE: Overexpression of p53 predicts organ preservation using induction chemotherapy and radiation in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group. Otolaryngol Head Neck Surg 1995;113:408-412.
9. Ang KK, Andratschke NH, Milas L: Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. Int J Radiat Oncol Biol Phys 2004;58:959-965.
10. Terhaard CH, Bongers V, van Rijk PP, Hordijk GJ: F-18-fluoro-deoxy- glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/pharyngeal cancer. Head Neck 2001;23:933-941.
11. Borggreven PA, Kuik DJ, Quak JJ, de Bree R, Snow GB, Leemans CR: Comorbid condition as a prognostic factor for complications in major surgery of the oral cavity and oropharynx with microvascular soft tissue reconstruction. Head Neck 2003:25:808-815.
12. Kumar P, Robbins KT: Treatment of advanced head and neck cancer with intraarterial cisplatin and concurrent radiation therapy: The 'RADPLAT' Protocol. Curr Oncol Rep 2001;3:59-65.
13. Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB: Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993;71: 452-456.
14. Brekel MWM van den, Castelijns JA, Stel HV, Golding RP, Meyer CJ, Snow GB: Modern imaging techniques and ultrasound guided aspiration cytology for the assessment of the neck node metastases: A prospective comparative study. Eur Arch Otorhinolaryngol 1993;250:11-17.
15. Brouwer J, de Bree R, Comans EFI, Castelijns JA, Hoekstra OS, Leemans CR: Positron emission tomography using [18F]fluorodeoxyglucose (FDG-PET) in the clinically negative neck: Is it likely to be superior? Eur Arch Otorhinolaryngol 2003, DOI 10.1007/s00405-003-0727-3 (Epub ahead of print).
16. de Bree R, Roos JC, Verel I, van Dongen GAMS, Snow GB: Radioimmunodiagnosis of lymph node metastases in head and neck cancer. Oral Diseases 2003;9:241-248.
17. Dünne AA, Budach VG, Wagner W, Werner JA: Management of N0 neck in head and neck cancer: Current controversies. Onkologie 2004;27:363-367.
18. Nieuwenhuis EJC, Castelijns JA, Pijpers R, van den Brekel MWM, Brakenhoff RH, van der Waal I, Snow GB, Leemans CR: Wait-and-see policy for the N0 neck in early stage oral and oropharyngeal SCC using ultrasonography-guided cytology: Is there a role for identification of the sentinel node? Head Neck 2002;24:282-289.
19. Shoaib T, Soutar DS, MacDonald DG, Camilleri IG, Dunaway DJ, Gray HW, McCurrach GM, Bessent RG, MacLeod TI, Robertson AG: The accuracy of head and neck carcinoma sentinel lymph node biopsy in the clinically N0 neck. Cancer 2001; 91:2077-2083.
20. Werner JA, Dunne AA, Ramaswamy A, Folz BJ, Lippert BM, Moll R, Behr T: Sentinel node detection in N0 cancer of the pharynx and larynx. Br J Cancer 2002;87:711-715.
21. de Bree R, Brouwer J, Comans EFI, Hoekstra OS, Snow GB, Leemans CR: The preliminary results of FDG-PET in screening for distant metastases and synchronous primary tumors below the clavicles in patients with head and neck cancer at initial evaluation; in Lippert BM, Werner JA (eds): Metastases in Head and Neck Cancer. Proceedings of the 2nd International Symposium. Marburg, Tectum, 2001, pp 155-159.
22. Wollenberg B, Walz A, Kolbow K, Pauli C, Chaubal S, Andratschke M: Clinical relevance of circulating tumor cells in the bone marrow of patients with SCCHN. Onkologie 2004;27:358-362.
23. Colnot DR, Quak JJ, Roos JC, de Bree R, Wilhelm AJ, Snow GB, van Dongen GAMS: Radioimmunotherapy in patients with head and neck squamous cell carcinoma: Initial experience. Head Neck 2001; 23:559-565.